Frost edit · Free shipping over $70 · Cool essentials
cardinal health glp-1 receptor agonist weight management diabetes treatments

cardinal health glp-1 receptor agonist weight management diabetes treatments Overview of GLP-1s Revolutionizing obesity treatment: The emerging

SKU: 9232224287
4.1
USD21.54 USD68.54

Pay in 4 interest-free payments of $5.38 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Aug 25 - Aug 30

Description

Molecular Characteristics Compound Name: Ipamorelin CAS Number: 170851-70-4 Peptide Length: 5 amino acids Molecular Formula: C38H49N9O5 Molecular Weight: ~711.9 g/mol Form: Lyophilized peptide powder Purity: 99% HPLC verified Stability Profile and Storage Recommendations Store lyophilized peptide at 20C Avoid repeated freeze-thaw cycles Protect from moisture and direct light Reconstituted solutions should be refrigerated Use sterile laboratory solvents for preparation Solubility and Reconstitution Options Sterile bacteriostatic water Sterile saline solutions Buffered aqueous laboratory solutions Biochemical assay buffers Laboratory-grade solvent systems Technical Specifications product Name Ipamorelin 5mg brand BioPeptide cas 170851-70-4 purity 99% (HPLC verified) unit Size 5mg vial form Lyophilized powder synthesis Solid-Phase Peptide Synthesis (SPPS) analytical HPLC and Mass Spectrometry molecular Structure Selective growth hormone secretagogue peptide stability Stable when stored at 20C Analytical Validation and Quality Assurance High-performance liquid chromatography purity verification Mass spectrometry molecular weight confirmation Peptide structural integrity validation Batch-to-batch analytical consistency testing Peptide stability verification Regulatory and Compliance Statement Ipamorelin supplied by BioPeptide is intended strictly for laboratory and scientific research use only

cardinal health glp-1 receptor agonist weight management diabetes treatments Overview of GLP-1s Revolutionizing obesity treatment: The emerging

J Clin Invest (2013) 123(6):27306

cardinal health glp-1 receptor agonist weight management diabetes treatments Overview of GLP-1s Revolutionizing obesity treatment: The emerging

The pharmacological consequence is the part that matters

cardinal health glp-1 receptor agonist weight management diabetes treatments Overview of GLP-1s Revolutionizing obesity treatment: The emerging

Endoscopic therapy: Endoscopic therapy involves the use of a flexible tube with a camera to locate and treat the bleeding source in the gastrointestinal tract

cardinal health glp-1 receptor agonist weight management diabetes treatments Overview of GLP-1s Revolutionizing obesity treatment: The emerging
Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

recommand products